Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $115,640.75 +1.80%
  • Ethereum $4,216.67 +3.72%
  • BNB $1,149.68 +1.99%
  • Optimism $0.47 +1.67%
  • Arbitrum $0.34 +3.90%
  • Solana $202.59 +1.76%
  • Polygon $0.22 +2.77%
  • Cosmos $3.24 -0.02%
  • Avalanche $20.69 +2.01%
  • Bitcoin $115,640.75 +1.80%
  • Ethereum $4,216.67 +3.72%
  • BNB $1,149.68 +1.99%
  • Optimism $0.47 +1.67%
  • Arbitrum $0.34 +3.90%
  • Solana $202.59 +1.76%
  • Polygon $0.22 +2.77%
  • Cosmos $3.24 -0.02%
  • Avalanche $20.69 +2.01%
Home / Jazz Pharmaceuticals / investors

Jazz Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
2
12
Jazz Pharmaceuticals is funded by 12 investors. Longitude Capital and Kohlberg Kravis Roberts are the most recent investors.
Investor Name Lead Investor Funding Round
Longitude Capital Yes Post-IPO Equity
Kohlberg Kravis Roberts Yes Series B
Kingsbridge Capital - Post-IPO Equity
Adams Street Partners - Series B
Beecken Petty O'Keefe & Company - Series B
EGS Healthcare Capital Partners - Series B
Golden Gate Capital - Series B
Lehman Brothers - Series B
Prospect Venture Partners - Series B
Thoma Cressey Equity Partners - Series B
Versant Ventures - Series B
Waud Capital Partners - Series B

Contact

Palo Alto,California,United States
6504962651
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions